Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Bio-rad avise les utilisateurs des lots de variant ii turbo hemoglobin a1c program reorder packs qu'ils doivent s'assurer que la ligne de base des chromatogrammes ne presente pas une pente ascendante. la possibilite existe que soit sous estimee la concentration d'a1c de certains echantillons.